Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Prospective, OL, Single-arm Clinical Study of Safety & Feasibility of Using Navigational Bronchoscopy to Perform Interstitial PD Therapy Using Photofrin® as Treatment in Subjects With Unresectable Solid Tumor in Peripheral Lung

NCT02916745 is registered in ClinicalTrials.gov with Concordia Laboratories Inc. as lead sponsor.

NCT NCT02916745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02916745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Prospective, OL, Single-arm Clinical Study of Safety & Feasibility of Using Navigational Bronchoscopy to Perform Interstitial PD Therapy Using Photofrin® as Treatment in Subjects With Unresectable Solid Tumor in Peripheral Lung
Lead sponsor
Concordia Laboratories Inc.
Phase
Phase 1
Overall status
Completed
Start date
January 26, 2017
Completion date
April 12, 2019
Enrollment
5 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

lung metastasis, non-small cell lung cancer (nsclc)